Astrazeneca Covid-19 Vaccine
-
{
- All
- News
- Videos
-
Possible New Links Between AstraZeneca Vaccine And Blood Clots
Scientists have identified a possible reason the AstraZeneca Plc Covid-19 vaccine may cause blood clots, after use of the shot was limited globally to prevent the rare side effect.
-
Australia Restricts AstraZeneca Vaccine For All Under 60 Due to Clotting Concerns
Australia recommended that AstraZeneca's Covid-19 jab should not be given to people under 60 on Thursday, a fresh blow to the country's glacial vaccine rollout.
-
British Woman In Cyprus Suffers Blood Clot After Receiving AstraZeneca COVID-19 Vaccine, Dies
A 39-year-old British woman died in a Cypriot hospital after a blood clotting incident after receiving the AstraZeneca Covid-19 vaccine, the official Cyprus News Agency said Monday.
-
2 AstraZeneca Doses Give Up to 90% Protection From Covid Symptoms: UK
Two doses of AstraZeneca Plc's Covid-19 vaccine provide about 85% to 90% protection against symptomatic disease, according to statistics released by Public Health England on Thursday.
-
Immediately Release AstraZeneca Vaccine Stockpile To India: US Lawmaker To Biden Administration
Underlining that the US has "special obligations" towards India, an influential American lawmaker on Monday urged the Biden administration to immediately share the unused stockpile of AstraZeneca COVID-19 vaccines with the country, which is facing an
-
Serum Institute Plans To Begin Vaccine Production Outside India: Report
The Serum Institute of India, which manufactures the AstraZeneca COVID-19 vaccine, is planning to start vaccine production in other countries as it struggles to meet supply commitments, its chief executive officer told The Times.
-
Covishield Comprises Over 90% Of 12.76 Crore Covid Vaccines Given So Far: Government Data
Covishield, from the Oxford/AstraZeneca stable, comprises over 90 per cent of the 12.76 crore COVID-19 vaccines administered across the country so far, according to government data on Wednesday.
-
AstraZeneca Could Have Vaccine Against South African Variant By End-2021: Report
A modified version of AstraZeneca's COVID-19 vaccine tailored to combat a coronavirus variant first documented in South Africa could be ready by the end of 2021, an AstraZeneca official in Austria said in an interview published on Sunday.
-
Angela Merkel Receives AstraZeneca Covid Vaccine
Chancellor Angela Merkel on Friday received her first dose of AstraZeneca's Covid-19 vaccine, more than two weeks after German authorities recommended use of the jab only for people aged 60 and over.
-
Four Died In Italy Due To Rare Blood Clots After AstraZeneca Shots: Report
Four people died in Italy from rare blood clots after they received the AstraZeneca COVID-19 vaccine, a report from the AIFA national pharmaceutical agency said on Thursday.
-
Denmark Drops AstraZeneca Vaccine Permanently Over Suspected Side Effects
Denmark announced Tuesday it would stop using the AstraZeneca Covid-19 vaccine altogether, becoming the first European country to do so over suspected rare but serious side effects.
-
Ireland To Limit AstraZeneca Covid Shot To Over-60s
Ireland's vaccine taskforce on Monday recommended the AstraZeneca coronavirus jab be limited to those aged over 60, following European reviews of evidence linking the shot to rare blood clotting events.
-
UK Reassures On AstraZeneca After Advising Under-30s Take Other Vaccines
British officials and ministers sought to shore up confidence in AstraZeneca's COVID-19 vaccine on Thursday, saying advice that most people under 30 should be offered alternative shots was not unusual and would not impact the pace of rollout.
-
India Changes Covishield Shelf Life To 9 Months From 6: Report
India's drug regulator has allowed the AstraZeneca COVID-19 vaccine to be used for up to nine months from its manufacture date, as opposed to the prescribed six months, according to a document reviewed by Reuters and a source.
-
AstraZeneca To Release More Data On US Covid Jab Trials "Within 48 Hours"
UK-based pharmaceutical giant AstraZeneca said Tuesday it will release further data "within 48 hours" on US trials of its Covid-19 vaccine, after health officials raised concerns about the initial information disclosed.
-
Possible New Links Between AstraZeneca Vaccine And Blood Clots
Scientists have identified a possible reason the AstraZeneca Plc Covid-19 vaccine may cause blood clots, after use of the shot was limited globally to prevent the rare side effect.
-
Australia Restricts AstraZeneca Vaccine For All Under 60 Due to Clotting Concerns
Australia recommended that AstraZeneca's Covid-19 jab should not be given to people under 60 on Thursday, a fresh blow to the country's glacial vaccine rollout.
-
British Woman In Cyprus Suffers Blood Clot After Receiving AstraZeneca COVID-19 Vaccine, Dies
A 39-year-old British woman died in a Cypriot hospital after a blood clotting incident after receiving the AstraZeneca Covid-19 vaccine, the official Cyprus News Agency said Monday.
-
2 AstraZeneca Doses Give Up to 90% Protection From Covid Symptoms: UK
Two doses of AstraZeneca Plc's Covid-19 vaccine provide about 85% to 90% protection against symptomatic disease, according to statistics released by Public Health England on Thursday.
-
Immediately Release AstraZeneca Vaccine Stockpile To India: US Lawmaker To Biden Administration
Underlining that the US has "special obligations" towards India, an influential American lawmaker on Monday urged the Biden administration to immediately share the unused stockpile of AstraZeneca COVID-19 vaccines with the country, which is facing an
-
Serum Institute Plans To Begin Vaccine Production Outside India: Report
The Serum Institute of India, which manufactures the AstraZeneca COVID-19 vaccine, is planning to start vaccine production in other countries as it struggles to meet supply commitments, its chief executive officer told The Times.
-
Covishield Comprises Over 90% Of 12.76 Crore Covid Vaccines Given So Far: Government Data
Covishield, from the Oxford/AstraZeneca stable, comprises over 90 per cent of the 12.76 crore COVID-19 vaccines administered across the country so far, according to government data on Wednesday.
-
AstraZeneca Could Have Vaccine Against South African Variant By End-2021: Report
A modified version of AstraZeneca's COVID-19 vaccine tailored to combat a coronavirus variant first documented in South Africa could be ready by the end of 2021, an AstraZeneca official in Austria said in an interview published on Sunday.
-
Angela Merkel Receives AstraZeneca Covid Vaccine
Chancellor Angela Merkel on Friday received her first dose of AstraZeneca's Covid-19 vaccine, more than two weeks after German authorities recommended use of the jab only for people aged 60 and over.
-
Four Died In Italy Due To Rare Blood Clots After AstraZeneca Shots: Report
Four people died in Italy from rare blood clots after they received the AstraZeneca COVID-19 vaccine, a report from the AIFA national pharmaceutical agency said on Thursday.
-
Denmark Drops AstraZeneca Vaccine Permanently Over Suspected Side Effects
Denmark announced Tuesday it would stop using the AstraZeneca Covid-19 vaccine altogether, becoming the first European country to do so over suspected rare but serious side effects.
-
Ireland To Limit AstraZeneca Covid Shot To Over-60s
Ireland's vaccine taskforce on Monday recommended the AstraZeneca coronavirus jab be limited to those aged over 60, following European reviews of evidence linking the shot to rare blood clotting events.
-
UK Reassures On AstraZeneca After Advising Under-30s Take Other Vaccines
British officials and ministers sought to shore up confidence in AstraZeneca's COVID-19 vaccine on Thursday, saying advice that most people under 30 should be offered alternative shots was not unusual and would not impact the pace of rollout.
-
India Changes Covishield Shelf Life To 9 Months From 6: Report
India's drug regulator has allowed the AstraZeneca COVID-19 vaccine to be used for up to nine months from its manufacture date, as opposed to the prescribed six months, according to a document reviewed by Reuters and a source.
-
AstraZeneca To Release More Data On US Covid Jab Trials "Within 48 Hours"
UK-based pharmaceutical giant AstraZeneca said Tuesday it will release further data "within 48 hours" on US trials of its Covid-19 vaccine, after health officials raised concerns about the initial information disclosed.
